# Aplenzin

NDC: 0187-5810
Generic name: bupropion hydrobromide
Labeler / Manufacturer: Bausch Health US, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20080423

FDA application: NDA022108

## Active ingredients

- BUPROPION HYDROBROMIDE: 174 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0187-5810"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0187-5810
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6494d2d9-0ce4-4126-b1c7-49684395942b